NCT01179152

Study of Preventive Treatment With Symbicort or Budicort Turbohaler in Childhood Asthma Return to School Epidemic

Childhood Asthma and Return to School: the September Epidemic Exacerbation in Israel.A Controlled Trial of the Effectiveness of Preventive Treatment With Symbicort or Budicort Turbuhaler

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 225 (estimated)
• Sponsor: Meir Medical Center · Academic / Other
• Sex: All
• Age: 6 Years – 18 Years
• Healthy volunteers: Not accepted

Summary

During the second week of September( week 38 of the year)there are recorded data of exacerbation of asthma all over the world, including Israel. A short preventive treatment of 6 weeks may reduce asthma exacerbation in children,reduce primary care and ER visiting and hospitalization.

Detailed description

During the second week of September( week 38 of the year)there are recorded data of exacerbation of asthma all over the world, including Israel. A short preventive treatment of 6 weeks may reduce asthma exacerbation in children,reduce primary care and ER visiting and hospitalization. We will study the effectiveness of Budicort or Symbicort turbuhaler as a preventive treatment in children aged 6-18 years.

Conditions

• Asthma Exacerbation

Interventions

Type	Name	Description
DRUG	Budesonide turbuhaler, Budesonide+Formoterol turbuhaler	Budesonide 200 mcg turbuhaler or Budesonide+Formoterol 160mcg turbuhaler

Timeline

• Start date: 2010-09-01
• Primary completion: 2011-10-01
• Completion: 2012-10-01
• First posted: 2010-08-11
• Last updated: 2012-03-19

Locations

1 site across 1 country: Israel